MTOR and triple-negative breast carcinoma: Overactivation of mTOR also commonly occurs in multiple cancer types [34, 35], some studies revealed that Aur-A/ERK1/2/mTOR formed an oncogenic cascade in triple-negative breast cancer (TNBC), and double inhibition of Aur-A and mTOR showed significant synergistic effects in TNBC models.